Neurogene
NGNE
#8030
Rank
A$0.35 B
Marketcap
$24.20
Share price
-1.23%
Change (1 day)
-64.36%
Change (1 year)

Neurogene (NGNE) - Cash on Hand

Cash on Hand as of September 2024 : A$0.22 Billion

According to Neurogene's latest financial reports the company has A$0.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurogene - Cash on Hand chart (from 2023 to 2024)

2024$0.1B$0.15B$0.2B$0.25B$0.3Bcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.28 B140.09%
2022-12-31A$0.12 B23.87%
2021-12-31A$97.3 M